Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3584]

Immunotherapy alone extended life for metastatic lung cancer patients with KRAS mutation

Immunotherapy alone extended life for metastatic lung cancer patients with KRAS mutation

Activating the brain's immune system against cancer prevents it from spreading

Activating the brain's immune system against cancer prevents it from spreading

Study reveals cancer immunotherapy patients at most risk of life-threatening side effects

Study reveals cancer immunotherapy patients at most risk of life-threatening side effects

AACR 2021: Cancer-killing virus therapy shows promise against inoperable skin cancers

AACR 2021: Cancer-killing virus therapy shows promise against inoperable skin cancers

AACR 2021: Immunotherapy response prediction using tumour mutational burden may differ between men and women with melanoma

AACR 2021: Immunotherapy response prediction using tumour mutational burden may differ between men and women with...

AACR 2021: Level of chromosomal abnormality in lung cancer may predict immunotherapy response

AACR 2021: Level of chromosomal abnormality in lung cancer may predict immunotherapy response

AACR 2021: Therapeutics Discovery researchers identify key biomarker for metabolic inhibitor

AACR 2021: Therapeutics Discovery researchers identify key biomarker for metabolic inhibitor

AACR 2021: Unselected autologous tumour infiltrating lymphocyte therapy shows early promise in patients with metastatic melanoma

AACR 2021: Unselected autologous tumour infiltrating lymphocyte therapy shows early promise in patients with...

AACR 2021: Neoadjuvant nivolumab plus chemotherapy increased pathological complete response rate in CheckMate-816 lung cancer trial

AACR 2021: Neoadjuvant nivolumab plus chemotherapy increased pathological complete response rate in CheckMate-816...

$AACR 2021: Bispecific CAR T-cell therapy shows early promise for relapsed or refractory B-cell lymphoma$

AACR 2021: Bispecific CAR T-cell therapy shows early promise for relapsed or refractory B-cell lymphoma

More from ecancer